fidaxomicin
Selected indexed studies
- Fidaxomicin versus vancomycin for Clostridium difficile infection. (N Engl J Med, 2011) [PMID:21288078]
- Fidaxomicin. (, 2012) [PMID:31644234]
- Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis. (Medicine (Baltimore), 2024) [PMID:39121324]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Fidaxomicin versus vancomycin for Clostridium difficile infection. (2011) pubmed
- Fidaxomicin. (2012) pubmed
- Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis. (2024) pubmed
- PMID:40857387 (2025) pubmed
- Fidaxomicin resistance in Clostridioides difficile: a systematic review and predictive modeling with RNA polymerase binding sites. (2024) pubmed
- Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. (2012) pubmed
- Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial. (2018) pubmed
- Fidaxomicin Use in the Pediatric Population with Clostridioides difficile. (2022) pubmed
- PMID:40857364 (2025) pubmed
- An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections. (2024) pubmed